https://expose-news.com/2026/05/29/bill-gates-project-releases-bacteria-infected/
Bill Gates-funded project in Colombia releases 30 million bacteria-infected mosquitoes per week
By Rhoda Wilson on May 29, 2026
Last year, the government of Burkina Faso terminated the Target Malaria project, a research initiative funded by the Gates Foundation and Open Philanthropy, due to biosafety risks, low impact and scientific sovereignty concerns.
Target Malaria aims to use genetically modified mosquitoes to control malaria. It is not the only mosquito project Gates has invested in. Gates has also invested in Oxitech’s genetically modified mosquito programmes. But his ambitions don’t stop there.
The Gates Foundation has also funded projects releasing mosquitoes infected with a modifiedWolbachiabacteria. This method of assaulting the natural world is born out of the Australian ‘World Mosquito Programme’.
In Colombia, the World Mosquito Programme has been releasing 30 million Wolbachia-infected mosquitoes a week.
What is Wolbachia?
Gates-Funded Genetically Modified Mosquitoes
Wolbachia-Infected Mosquitoes
Mosquito Borne Viruses They Say They Are Trying To Stop
Are Modified Wolbachia Bioweapons?
Gates-Funded Genetically Modified Mosquitoes
In August 2025, Burkina Faso suspended and terminated the Target Malaria project, a research initiative funded by the Gates Foundation and Open Philanthropy, which began in the country in 2012 as part of a broader international effort to use gene-based technology in disease control.
The military-led government, headed by Captain Ibrahim Traoré, ordered the immediate halt of all activities involving genetically modified mosquitoes aimed at eradicating malaria, citing biosafety risks, low impact and scientific sovereignty.
The government cited the need to prioritise public health and environmental safety over the controversial biotechnology, stating that all remaining mosquito samples would be destroyed.
Related:
Burkina Faso Stops Gates Foundation’s Anti-Malaria Campaign, Nigeria Eye, 23 August 2025
Burkina Faso closes Gates Foundation, Open Philanthropy funded malaria programme, Alliance Magazine, 26 August 2025
Burkina Faso Halts a Malaria Programme Backed by Bill and Melinda Gates Foundation, 25 August 2025
Target Malaria is an international research consortium dedicated to developing and distributing novel genetic technologies to control malaria in Africa. It receives its core funding primarily from the Gates Foundation (formerly the Bill & Melinda Gates Foundation) and Coefficient Giving (formerly the Open Philanthropy Project Fund).
Gates is obsessed with mosquitoes. “He’s been pushing for the idea of using genetically modified mosquitoes to eliminate the disease since 2016. That’s just one year after Oxitec finished its first mass mosquito release in Brazil,” Futurism, which is a Gates fan, said.
The Gates Foundation funds genetically modified mosquito research primarily in sub-Saharan Africa, the Americas and South Asia.
In 2023, the Foundation invested US$15 million in the Transmission Zero programme, led by Imperial College London and the Ifakara Health Institute in Tanzania (“IHI”), in partnership with the Tanzanian National Institute of Medical Research, aiming to conduct field trials by 2027.